Paediatric anaesthesia & critical care

Effects of avoidance versus use of neuromuscular blocking agents for facilitation of tracheal intubation in children and infants: A systematic review with meta-analysis and trial sequential analysis

Eur J AnaesthesiolPublished Systematic review and meta-analysis of randomised trials

Pooled resultResult — go to the resultRelative risk 3.47 95% CI 2.52–4.77

Authors' conclusion

Using NMBAs for facilitation of tracheal intubation reduces the incidence of difficult tracheal intubation compared to avoidance of NMBA in children and infants.

Study context

Population
Paediatric patients undergoing tracheal intubation (oral or nasal) by direct or video laryngoscopy for any procedure requiring GA
Participants
2,276 patients · 47 RCTs
Comparison
Avoidance vs use of NMBA for facilitation of tracheal intubation
Outcome
Incidence of difficult tracheal intubation
Methodological detailstrial sequential analysis, 3 trials at low risk of bias
  • Trial sequential analysis
  • 3 trials at low risk of bias

Pooled result

As reported in the abstract

Relative risk

3.47

95% CI 2.52–4.77

P < 0.001

Avoidance of NMBAs vs Use of NMBA
RR 3.47 (95% CI 2.52–4.77); P < 0.001

Further pooled results

Difficult tracheal intubation (trial sequential analysis)

α-spending adjusted RR when avoiding neuromuscular blocking agents (NMBAs)
3.68 (95% CI, 2.22 to 6.11; α = 5%, β = 90%)
  • Trial sequential analysis

Safety

Serious adverse events

No significant increased risk with avoidance vs use of NMBA
  • Very low certainty of evidence

Original publication

Effects of avoidance versus use of neuromuscular blocking agents for facilitation of tracheal intubation in children and infants: A systematic review with meta-analysis and trial sequential analysis. Eur J Anaesthesiol. Published 2 February 2026. doi:10.1097/eja.0000000000002358

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.